Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Gerards

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Annals of the Rheumatic Diseases|November 6, 2004
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritisA D Fraser, A W R van Kuijk, R Westhovens, et al.
Annals of the Rheumatic Diseases|March 14, 2003
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trialA H Gerards, R B M Landewé, A P A Prins, et al.
Arthritis Research & Therapy|February 1, 2018
Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?D F Ten Cate, J W G Jacobs, W A A Swen, et al.
Annals of the Rheumatic Diseases|August 5, 2011
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritisN B Klarenbeek, R Koevoets, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-upM van den Broek, L Dirven, J K de Vries-Bouwstra, et al.
Arthritis Research & Therapy|January 12, 2022
Sex-specific differences and how to handle them in early psoriatic arthritisE Passia, M Vis, L C Coates, et al.
Annals of the Rheumatic Diseases|June 9, 2012
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trialP H de Jong, J M Hazes, P J Barendregt, et al.
Annals of the Rheumatic Diseases|June 11, 2016
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trialT M Kuijper, J J Luime, P H P de Jong, et al.
Annals of the Rheumatic Diseases|May 3, 2014
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trialP H de Jong, J M Hazes, H K Han, et al.
Scandinavian Journal of Rheumatology|October 21, 2020
Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis studyF R Kasiem, J J Luime, M Vis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|November 6, 2004
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritisA D Fraser, A W R van Kuijk, R Westhovens, et al.
Annals of the Rheumatic Diseases|March 14, 2003
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trialA H Gerards, R B M Landewé, A P A Prins, et al.
Arthritis Research & Therapy|February 1, 2018
Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?D F Ten Cate, J W G Jacobs, W A A Swen, et al.
Annals of the Rheumatic Diseases|August 5, 2011
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritisN B Klarenbeek, R Koevoets, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-upM van den Broek, L Dirven, J K de Vries-Bouwstra, et al.
Arthritis Research & Therapy|January 12, 2022
Sex-specific differences and how to handle them in early psoriatic arthritisE Passia, M Vis, L C Coates, et al.
Annals of the Rheumatic Diseases|June 9, 2012
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trialP H de Jong, J M Hazes, P J Barendregt, et al.
Annals of the Rheumatic Diseases|June 11, 2016
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trialT M Kuijper, J J Luime, P H P de Jong, et al.
Annals of the Rheumatic Diseases|May 3, 2014
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trialP H de Jong, J M Hazes, H K Han, et al.
Scandinavian Journal of Rheumatology|October 21, 2020
Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis studyF R Kasiem, J J Luime, M Vis, et al.
Pageof 3